A detailed history of First National Bank Of Mount Dora, Trust Investment Services transactions in Abb Vie Inc. stock. As of the latest transaction made, First National Bank Of Mount Dora, Trust Investment Services holds 56,248 shares of ABBV stock, worth $9.44 Million. This represents 2.62% of its overall portfolio holdings.

Number of Shares
56,248
Previous 49,828 12.88%
Holding current value
$9.44 Million
Previous $8.55 Million 29.97%
% of portfolio
2.62%
Previous 2.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $1.05 Million - $1.28 Million
6,420 Added 12.88%
56,248 $11.1 Million
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $1.31 Million - $1.53 Million
8,488 Added 20.53%
49,828 $8.55 Million
Q1 2024

Apr 10, 2024

SELL
$159.82 - $182.1 $251,876 - $286,989
-1,576 Reduced 3.67%
41,340 $7.53 Million
Q4 2023

Jan 05, 2024

SELL
$137.6 - $154.97 $177,916 - $200,376
-1,293 Reduced 2.92%
42,916 $6.65 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $140,135 - $162,227
-1,049 Reduced 2.32%
44,209 $6.59 Million
Q2 2023

Jul 07, 2023

SELL
$132.51 - $164.9 $898,947 - $1.12 Million
-6,784 Reduced 13.04%
45,258 $6.1 Million
Q1 2023

Apr 12, 2023

BUY
$144.61 - $166.54 $307,296 - $353,897
2,125 Added 4.26%
52,042 $8.29 Million
Q4 2022

Jan 05, 2023

BUY
$138.31 - $165.87 $29,045 - $34,832
210 Added 0.42%
49,917 $8.07 Million
Q3 2022

Oct 06, 2022

BUY
$134.21 - $153.93 $462,353 - $530,288
3,445 Added 7.45%
49,707 $6.67 Million
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $61,516 - $78,207
-447 Reduced 0.96%
46,262 $7.09 Million
Q1 2022

Apr 06, 2022

BUY
$131.98 - $163.75 $886,245 - $1.1 Million
6,715 Added 16.79%
46,709 $7.57 Million
Q4 2021

Jan 10, 2022

BUY
$107.43 - $135.93 $107 - $135
1 Added 0.0%
39,994 $5.42 Million
Q3 2021

Oct 06, 2021

SELL
$106.4 - $120.78 $75,331 - $85,512
-708 Reduced 1.74%
39,993 $4.31 Million
Q2 2021

Jul 02, 2021

SELL
$105.21 - $117.21 $95,846 - $106,778
-911 Reduced 2.19%
40,701 $4.59 Million
Q1 2021

Apr 05, 2021

SELL
$102.3 - $112.62 $1.22 Million - $1.34 Million
-11,918 Reduced 22.26%
41,612 $4.5 Million
Q4 2020

Jan 06, 2021

BUY
$80.49 - $108.67 $3,702 - $4,998
46 Added 0.09%
53,530 $5.74 Million
Q3 2020

Oct 08, 2020

BUY
$85.91 - $100.83 $82,387 - $96,695
959 Added 1.83%
53,484 $4.69 Million
Q2 2020

Jul 08, 2020

SELL
$73.37 - $98.18 $363,621 - $486,580
-4,956 Reduced 8.62%
52,525 $5.16 Million
Q1 2020

Apr 03, 2020

SELL
$64.5 - $97.79 $171,118 - $259,436
-2,653 Reduced 4.41%
57,481 $4.38 Million
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $29,573 - $37,002
410 Added 0.69%
60,134 $5.32 Million
Q3 2019

Oct 09, 2019

BUY
$62.98 - $75.72 $74,127 - $89,122
1,177 Added 2.01%
59,724 $4.52 Million
Q2 2019

Jul 08, 2019

BUY
$65.7 - $83.98 $65,371 - $83,560
995 Added 1.73%
58,547 $4.26 Million
Q1 2019

Apr 02, 2019

BUY
$77.14 - $90.79 $776,954 - $914,436
10,072 Added 21.21%
57,552 $4.64 Million
Q4 2018

Jan 03, 2019

SELL
$77.85 - $96.01 $86,569 - $106,763
-1,112 Reduced 2.29%
47,480 $4.38 Million
Q3 2018

Oct 09, 2018

SELL
$88.91 - $98.84 $1.52 Million - $1.69 Million
-17,122 Reduced 26.06%
48,592 $4.6 Million
Q2 2018

Jul 13, 2018

BUY
$89.78 - $106.23 $149,483 - $176,872
1,665 Added 2.6%
65,714 $6.09 Million
Q1 2018

Apr 04, 2018

BUY
$92.01 - $123.21 $753,009 - $1.01 Million
8,184 Added 14.65%
64,049 $6.06 Million
Q4 2017

Jan 08, 2018

SELL
$89.56 - $98.21 $411,976 - $451,766
-4,600 Reduced 7.61%
55,865 $5.4 Million
Q3 2017

Oct 05, 2017

BUY
$69.85 - $89.22 $4.22 Million - $5.39 Million
60,465
60,465 $5.37 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First National Bank Of Mount Dora, Trust Investment Services Portfolio

Follow First National Bank Of Mount Dora, Trust Investment Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Mount Dora, Trust Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Mount Dora, Trust Investment Services with notifications on news.